Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Shares Outstanding (Diluted Average): 2022-2025

Historic Shares Outstanding (Diluted Average) for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $228.0 million.

  • Gossamer Bio's Shares Outstanding (Diluted Average) rose 0.72% to $228.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $228.0 million, marking a year-over-year increase of 0.72%. This contributed to the annual value of $226.2 million for FY2024, which is 48.23% up from last year.
  • Per Gossamer Bio's latest filing, its Shares Outstanding (Diluted Average) stood at $228.0 million for Q3 2025, which was up 0.31% from $227.3 million recorded in Q2 2025.
  • Gossamer Bio's 5-year Shares Outstanding (Diluted Average) high stood at $238.5 million for Q2 2024, and its period low was $75.9 million during Q1 2022.
  • Over the past 3 years, Gossamer Bio's median Shares Outstanding (Diluted Average) value was $226.2 million (recorded in 2024), while the average stood at $194.1 million.
  • As far as peak fluctuations go, Gossamer Bio's Shares Outstanding (Diluted Average) surged by 149.92% in 2024, and later dropped by 4.72% in 2025.
  • Gossamer Bio's Shares Outstanding (Diluted Average) (Quarterly) stood at $84.6 million in 2022, then soared by 80.46% to $152.6 million in 2023, then soared by 48.23% to $226.2 million in 2024, then increased by 0.72% to $228.0 million in 2025.
  • Its last three reported values are $228.0 million in Q3 2025, $227.3 million for Q2 2025, and $226.8 million during Q1 2025.